EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023

Japanese Society of Nephrology

Clinical and Experimental Nephrology · 2024-06 · 28 (6) · 473-495

DOI: 10.1007/s10157-024-02497-4 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical and Experimental Nephrology, online erschienen am 07.05.2024. Verfasst von Japanese Society of Nephrology. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Evidence-Based Medicine. Die Arbeit wurde bisher 82-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicEvidence-Based MedicineHumansNephrology

Zitieren

APA

Japanese Society of Nephrology (2024). Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023. Clinical and Experimental Nephrology, 28(6), 473-495. https://doi.org/10.1007/s10157-024-02497-4

Vancouver

Japanese Society of Nephrology. Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023. Clinical and Experimental Nephrology. 2024;28(6):473-495. doi:10.1007/s10157-024-02497-4

BibTeX
@article{JapaneseSocietyofNephrology2024,
  author = {Japanese Society of Nephrology, Japanese Society of Nephrology},
  title = {Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023},
  journal = {Clinical and Experimental Nephrology},
  year = {2024},
  volume = {28},
  number = {6},
  pages = {473--495},
  doi = {10.1007/s10157-024-02497-4}
}
Kostenlos starten →